Navigation Links
Stanford/Packard study shows no benefit from drug widely used to prevent premature births
Date:11/25/2008

and hearing problems. The earlier the delivery, the greater the risks. That means doctors are very motivated to help women in early labor stay pregnant as long as possible. A recent survey by the Society for Maternal-Fetal Medicine found 29 percent of obstetricians prescribed drugs to keep such patients from re-entering early labor. Of those, 79 percent said nifedipine was their first-choice therapy.

Lyell's team recruited 71 women who had been successfully treated for preterm labor between 24 and 34 weeks of pregnancy. The women were then randomly assigned to receive doses of nifedipine or placebo every six hours until 37 weeks of pregnancy or until delivery, whichever came first. The researchers hoped nifedipine would prevent preterm labor from re-starting. They evaluated whether subjects' pregnancies lasted to 37 weeks and measured how long delivery was delayed. They also noted the babies' gestational age at delivery, birth weight and complications of prematurity.

The team saw no differences between nifedipine and placebo for any measurement. About 40 percent of women in both groups reached 37 weeks of pregnancy, with delivery delayed an average of a month. Babies' average health was the same in both groups, too.

Lyell cautioned that the study was designed to detect a 50 percent improvement in delayed deliveries. If nifedipine confers a smaller advantage, it would not have been spotted in this study, she said. Lyell thinks a larger study of nifedipine is warranted. "A small benefit would be especially significant at early gestational ages, and less so later on. But overall, there's no benefit to prematurity."

Based on the current lack of data to support this drug, Lyell believes obstetricians should proceed with caution. "All medications have side effects," she said. Though nifedipine has a fairly good safety record, a few case reports link it to dangerously low blood pressure in pregnant women.

"If something has not
'/>"/>

Contact: Erin Digitale
digitale@stanford.edu
650-724-9175
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Hypnosis helped Stanford/Packard physicians pinpoint cause of childrens seizures
2. Antibiotics can prevent wound complications of childbirth, Stanford/Packard study finds
3. Asian-white couples face distinct pregnancy risks, Stanford/Packard
4. Penn study finds pro-death proteins required to regulate healthy immune function
5. New study shows promise in reducing surgical risks associated with surgical bleeding
6. Study, meta-analysis examine factors associated with death from heatstroke
7. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
8. Study says COPD testing is not measuring up
9. Preclinical study suggests organ-transplant drug may aid in lupus fight
10. Ability to cope with stress can increase good cholesterol in older white men, study finds
11. High alcohol consumption increases stroke risk, Tulane study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)...ggers, experts advise , , SATURDAY, Dec. 5...ple with allergies and asthma can have bad reactio...special steps to prevent sneezing and wheezing, ac... and Immunology (ACAAI). , Those who are allergic ...ificial plants, but both live and artificial trees...
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
Breaking Medicine News(10 mins):Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
...TA, Fla., May 21 As a health care practitioner, T... diagnosed with ovarian cancer, she knew her progn... with a clinic in Mexico offering effective new tr...Mexico for cutting edge alternative treatments. , ...
...RK, May 21 Immtech Pharmaceuticals, Inc. (OTC: IM...gin trading its common stock on the Pink OTC Marke...09 under the ticker symbol "IMMP". , , As announc...e Company,s common stock. The Corporate Complianc...
...ic Times Bring Experienced Nurses Back To Job Mark...r openings for new nurses at hospitals -- a result...sing shortage, according to Deloras Jones, RN, MS,...n in admissions is just one factor in the job mark...
...t procedure allows longer filtering, which experts...ws) -- Nighttime dialysis, done while people are a...t is probably better for their health as well, a n... actually takes longer but is done while a person ...
...ds mice lacking certain gene showed fewer signs of... News) -- A protein that might be linked to allerg...rchers, who said their finding could lead to new d...normal mice, those lacking the gene for TRPA1 had ...
...GTON, May 21 The following is a statement from ...Free Kids: , , (Logo: http://www.newscom.com/c...ign for Tobacco-Free Kids applauds U.S. Senator Pa... including the authority to crack down on tobacco ...
Other Medicine News:Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:Immtech to be Listed on OTC Market 2Health News:Hard Times for Nursing Hires Doesn't Signal End to Shortage According to California Institute for Nursing & Health Care 2Health News:Sleeping Through Dialysis May Be the Way to Go 2Health News:Sleeping Through Dialysis May Be the Way to Go 3Health News:Sen. Patty Murray Votes to Protect America's Kids from Tobacco 2
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Chicago Cosmetic Dentistry Practice Offers Ultra Thin Futuristic Lumineers Dental Veneers to Brighten Smiles 52729 1Chicago Cosmetic Dentistry Practice Offers Ultra Thin Futuristic Lumineers Dental Veneers to Brighten Smiles 52729 2Chicago Cosmetic Dentistry Practice Offers Ultra Thin Futuristic Lumineers Dental Veneers to Brighten Smiles 52729 3Moms Registered Dietitian Develop the First All In One Prenatal Vitamin in a Great Tasting Drink Mix 52727 1Moms Registered Dietitian Develop the First All In One Prenatal Vitamin in a Great Tasting Drink Mix 52727 2Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser Therapy US 52725 1Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser Therapy US 52725 2
... 24 Headlines claiming "soy,products lower sperm ...e,preliminary study that Dr. Jorge Chavarro, publi...ollected intake of soyfoods and not on,specific di... by many,issues, thus I feel the results should be...Tammy Hedlund, a researcher in prostate cancer,pre...
...4 MacroChem Corporation (OTC,Bulletin Board: MACM...ial,involving 37 patients who completed a 48-week,...study of EcoNail, a topical antifungal,lacquer for... composite,primary efficacy endpoint of the trial ...negative fungal culture and negative KOH) and clea...
Other Medicine Technology:Soyfoods Do Not Impact Sperm Count 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: